United States: CMS Proposes Increased Transparency Of Hospice Quality Data In Annual Payment Update

SUMMARY

On April 21, 2016, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule regarding updates to fiscal year (FY) 2017 Medicare payment rates and the wage index for hospices serving Medicare beneficiaries. In the proposed rule, CMS signals an increased focus on hospice quality issues, proposing to make hospice quality data public as early as this summer and create a consumer-facing Hospice Compare website that will ultimately provide star ratings for hospices similar to those currently available for nursing homes in addition to additional quality measures.

IN DEPTH

On April 21, 2016, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule regarding updates to fiscal year (FY) 2017 Medicare payment rates and the wage index for hospices serving Medicare beneficiaries. In the proposed rule, CMS signals an increased focus on hospice quality issues, proposing to make hospice quality data public as early as this summer and create a consumer-facing Hospice Compare website that will ultimately provide star ratings for hospices similar to those currently available for nursing homes. The payment update also includes new quality measures, proposes to replace one of the key hospice data collection systems with a patient assessment instrument and announces increased monitoring of length of stay data and other key metrics. These changes are consistent with CMS's move toward increased transparency in quality data across a broad range of Medicare providers. CMS continues to work toward more sophisticated oversight of the hospice industry, with payment reforms and program integrity monitoring that reflects the agency's tighter regulatory control over other post-acute providers.

CMS Proposes Two Percent Increase in Hospice Payments

If the proposed payment update is finalized, hospices will receive a two percent increase in payments in FY 2017, which CMS projects will have an overall economic impact of approximately $330 million in increased payments to hospices during FY 2017. The update to the hospice payment percentage is based on the hospital inpatient market basket index, which CMS estimates at 2.8 percent for FY 2017. However, the market basket value must be reduced to reflect an approximate 0.5 percent reduction for productivity adjustments and an additional reduction of 0.3 percent, both mandated by the Affordable Care Act (ACA).

CMS Proposes Changes to Quality Reporting and Transparency

Much of the focus of the proposed rule is on improving quality measurement for hospices and increasing the transparency of hospice quality data. CMS proposes: (1) updating the Hospice Quality Reporting Program (HQRP) to include two new quality measures; (2) publically sharing HQRP quality measures through a public dataset and a newly created Hospice Compare website; and (3) replacing one of the current hospice data collection mechanisms with a patient assessment tool.

New Quality Measures

CMS proposes to update the Hospice Quality Reporting Program to include two new measures:

  • Hospice Visits When Death is Imminent. This proposed new measure will be used to assess hospice staff visits to patients and caregivers in the last week of a patient's life. Currently, HQRP measures do not address care beyond the hospice initial and comprehensive assessment period, nor do any current HQRP measures relate to the assessment of hospice staff visits to patients and caregivers in the last week of life. The proposed measure would assess two components:

    • The percentage of patients receiving at least one visit from registered nurses, physicians, nurse practitioners or physician assistants in the last three days of life; and
    • The percentage of patients receiving at least two visits from medical social workers, chaplains, spiritual counselors, licensed practical nurses or hospice aides in the last seven days of life.
    CMS projects that collecting information on hospice claims about both clinical and non-clinical visits during this time period will encourage hospices to visit patients and caregivers and provide services that will improve quality of life during the patients' last days of life. Citing clinical practice guidelines but no specific studies, CMS is taking the position that clinician visits to patients at the end of life are associated with improved outcomes such as decreased risk of hospitalization, emergency room visits and hospital death, and are also shown to reduce caregiver distress and improve patient and caregiver satisfaction with care.

    Data for this proposed new measure would be collected via the existing Hospice Item Set (HIS). CMS proposes that four new items be added to the HIS-Discharge record to collect the necessary data elements for the measure, beginning April 1, 2017.
  • Hospice and Palliative Care Composite Process. The second proposed measure would be used to assess the percentage of hospice patients who received care processes that were consistent with existing guidelines at the time of admission. This measure will utilize data on a total of seven individual care processes that are already collected via the HIS, including the six National Quality Forum (NQF)-endorsed quality measures and one modified NQF-endorsed quality measure. CMS indicates that a composite measure would ensure that all hospice patients receive a comprehensive assessment for both physical and psychosocial needs at admission. CMS's objective is to provide beneficiaries and providers with a single measure regarding the overall quality and completeness of assessment of patient needs at hospice admission, which can then be used to meaningfully and easily compare quality across hospice providers and increase transparency. This new measure appears to support CMS's goals regarding publication of hospice quality data, as described in more detail below.

Increased Transparency of Hospice Quality Data

Consistent with CMS's trend towards greater transparency and publication of datasets in other Medicare programs, CMS proposes to make data from all seven HQRP quality measures publicly available during 2016 through an online dataset. While Section 3004 of the ACA requires CMS to establish procedures for making hospice quality data available to the public, this is the first time that CMS has proposed a process for publishing such data. As a first step, CMS plans to publish demographic data (i.e., addresses, phone numbers and scope of services services) regarding hospice agencies enrolled as Medicare providers. CMS will publish the more comprehensive quality data later this spring or summer.

CMS also proposes to create a new consumer-facing Hospice Compare website to publish hospice quality data in an easily comparable format in the spring or summer of 2017. CMS asserts that public reporting through the Hospice Compare website will provide valuable information regarding the quality of care provided by Medicare certified hospice agencies throughout the nation. Consumers will be able to search for all Medicare approved hospice providers that serve their city or zip code, and then find the agencies offering the types of services they need, along with provider quality information. Like other CMS provider comparison websites, the Hospice Compare site will eventually give rise to a new system that gives each hospice a rating between one and five stars. According to CMS, and as required by the ACA, hospices will have prepublication access to their own quality data, enabling correction of any issues or inaccuracies before public posting on the Hospice Compare website. Concerns continue to surface surrounding CMS's various provider comparison tools. For example, a number of provider groups continue to question whether existing measures appropriately serve as a proxy for perceived overall quality in a five star rating.

Long-Term Proposal to Replace HIS with Patient Assessment Tool

CMS also proposes a more long-term goal of replacing the current HIS chart abstraction/data collection tool with a patient assessment instrument that would accumulate data currently collected through HIS as well as additional clinical information. CMS indicates in the proposed rule that such a patient assessment tool may support new quality measures and future payment refinements by allowing the collection of more detailed clinical information, beyond the patient diagnosis and comorbidities that are currently reported on hospice claims, concurrent with the provision of care instead of retrospectively. This patient assessment tool would not replace other existing data submission requirements set forth in the Medicare Hospice Conditions of Participation (i.e., initial nursing and comprehensive assessments), other non-HIS data sources utilized for HQRP measures such as the Hospice CAHPS survey or the regular submission of claims data.

Increased Oversight Over Length of Stay Data and Other Metrics

As announced in last year's payment rate notice, CMS implemented a new two-tier per diem payment rate for routine home care provided to hospice patients in FY 2016. Under the new payment methodology, hospices are reimbursed at a higher base rate for a patient's first 60 days of hospice care, and at a reduced base payment rate for all days following day 60 with a supplemental payment made available for care provided in the last seven days of life if certain criteria are met.

Concurrent with the implementation of this new payment methodology, CMS plans to utilize a contractor, Acumen, LLC, to monitor key metrics on a provider-specific level to assess how these changes in routine home care reimbursement are affecting hospice lengths of stay and other treatment patterns. The assessed metrics will include hospice diagnosis reporting; lengths of stay; live discharge patterns; non-hospice spending for Parts A, B, and D during a hospice election; trends of live discharge at or around day 61 of hospice care; and readmissions after a 60 day lapse following a live discharge.

CMS indicates in the proposed rule that these metrics will also be monitored for program integrity purposes, for example, to identify any new patterns of potential fraud, waste and abuse. Increased oversight of these metrics will require hospice providers to focus internally on the appropriateness of admission, discharge, and readmission determinations.

Commencement of Medicare Care Choices Model

In the proposed rule, CMS also discusses the commencement of the five-year Medicare Care Choices Model (MCCM), which allows beneficiaries with certain advanced diseases to receive hospice-like support services from participating hospices while receiving care from other Medicare providers for their terminal illnesses. Medicare beneficiaries and dual-eligible individuals with advanced cancers, chronic obstructive pulmonary disease, congestive heart failure or HIV/AIDS who otherwise qualify for the hospice benefit will be eligible to receive these services from participating hospices. CMS's goal is to determine whether greater and earlier use of the Medicare and Medicaid hospice benefits will improve patient quality of life, improve quality of care, increase beneficiary, family, and caregiver satisfaction and reduce Medicare and Medicaid expenditures. A total of 130 hospices from 39 states are participating in the model and the first cohort of providers made services available in January 2016.

Looking Ahead

The proposed advancements announced in the FY 2017 payment rate update are consistent with CMS's increasing sophistication in the area of hospice reimbursement and quality monitoring. These changes will continue to more closely align the hospice program with other highly regulated post-acute care settings. The widespread availability of easily comparable quality data will ultimately have an industry-wide impact on hospice services, including admission patterns, with hospice providers being forced to also compete on the basis of certain performance metrics (that may or may not be tied to value for all providers and beneficiaries). A key question will be whether metrics are sufficiently supported by clinical and health economic evidence coupled with diverse beneficiary and caregiver values. Full implementation of these objectives will take time, but the initial publications of data may have both anticipated and unanticipated impacts on hospice services.

CMS Proposes Increased Transparency Of Hospice Quality Data In Annual Payment Update

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
BakerHostetler
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
BakerHostetler
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions